Skip to main content
Log in

Etanercept for the Management of Oral Lichen Planus

  • Correspondence
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sugerman PB, Savage NW, Walsh LJ. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13 (4): 350–65

    Article  PubMed  CAS  Google Scholar 

  2. Spencer-Green G. Etanercept (Enbrel): update on therapeutic use. Ann Rheum Dis 2000 Nov; 59 Suppl.1: 46–9

    Article  Google Scholar 

  3. Robinson ND, Guitart J. Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Dermatol 2003 Oct; 139 (10): 1259–62

    Article  PubMed  Google Scholar 

  4. Chiang KY, Abhyankar S, Bridges K. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002 Feb 27; 73 (4): 665–7

    Article  PubMed  CAS  Google Scholar 

  5. Maender JL, Krishnan RS, Angel TA. Complete resolution of generalized lichen planus after treatment with thalidomide. J Drugs Dermatol 2005 Jan-Feb; 4 (1): 86–8

    PubMed  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this article. The author has no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yarom, N. Etanercept for the Management of Oral Lichen Planus. Am J Clin Dermatol 8, 121 (2007). https://doi.org/10.2165/00128071-200708020-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200708020-00010

Keywords

Navigation